Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zongfu Pan, Lu Li, Yangyang Qian, Xinyang Ge, Xiaoping Hu, Yiwen Zhang, Minghua Ge & Ping Huang. (2020) The differences of regulatory networks between papillary and anaplastic thyroid carcinoma: an integrative transcriptomics study. Cancer Biology & Therapy 21:9, pages 853-862.
Read now
Read now
Articles from other publishers (15)
Chen-chen Wang, Dan-dan Lu, Ming-hong Shen, Ru-lei Chen, Zhi-hong Zhang & Jing-huan Lv. (2023) Clinical value of Cyclin D1 and P21 in the differential diagnosis of papillary thyroid carcinoma. Diagnostic Pathology 18:1.
Crossref
Crossref
Jaime M. Pita, Eric Raspé, Katia Coulonval, Myriam Decaussin-Petrucci, Maxime Tarabichi, Geneviève Dom, Frederick Libert, Ligia Craciun, Guy Andry, Laurence Wicquart, Emmanuelle Leteurtre, Christophe Trésallet, Laura A. Marlow, John A. Copland, Cosimo Durante, Carine Maenhaut, Branca M. Cavaco, Jacques E. Dumont, Giuseppe Costante & Pierre P. Roger. (2023) CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas. Frontiers in Endocrinology 14.
Crossref
Crossref
Hatice OZİSİK, Berrin OZDİL, Merve OZDEMİR, Murat SİPAHİ, Mehmet ERDOĞAN, Sevki CETİNKALP, Gokhan OZGEN, Fusun SAYGİLİ, Gulgun OKTAY & Huseyin AKTUG. (2022) The morphological analysis of anaplastic thyroid cancer cell lineAnaplastik tiroid kanseri hücre hattının morfolojik analizi. Ege Tıp Dergisi 61:3, pages 460-464.
Crossref
Crossref
Stefan Steurer, Jana Schneider, Franziska Büscheck, Andreas M. Luebke, Martina Kluth, Claudia Hube-Magg, Andrea Hinsch, Doris Höflmayer, Sören Weidemann, Christoph Fraune, Katharina Möller, Anne Menz, Christian Bernreuther, Patrick Lebok, Guido Sauter, Ronald Simon, Frank Jacobsen, Ria Uhlig, Waldemar Wilczak, Sarah Minner, Eike Burandt, Rainer H. Krech, David Dum, Till Krech, Andreas H. Marx & Till S. Clauditz. (2021) Immunohistochemically detectable thyroglobulin expression in extrathyroidal cancer is 100% specific for thyroidal tumor origin. Annals of Diagnostic Pathology 54, pages 151793.
Crossref
Crossref
E. Guadagno, E. D’Avella, P. Cappabianca, A. Colao & M. Del Basso De Caro. (2020) Ki67 in endocrine neoplasms: to count or not to count, this is the question! A systematic review from the English language literature. Journal of Endocrinological Investigation 43:10, pages 1429-1445.
Crossref
Crossref
Jaya Amaram-Davila, Mellar Davis & Akhila Reddy. (2020) Opioids and Cancer Mortality. Current Treatment Options in Oncology 21:3.
Crossref
Crossref
Raffaele Pezzani, Loris Bertazza, Elisabetta Cavedon, Simona Censi, Jacopo Manso, Sara Watutantrige-Fernando, Gianmaria Pennelli, Francesca Galuppini, Susi Barollo & Caterina Mian. (2019) Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients. International Journal of Endocrinology 2019, pages 1-7.
Crossref
Crossref
Mu Liu, Yu-lu Qiu, Tong Jin, Yin Zhou, Zhi-yuan Mao & Yong-jie Zhang. (2018) Meta-analysis of microarray datasets identify several chromosome segregation-related cancer/testis genes potentially contributing to anaplastic thyroid carcinoma. PeerJ 6, pages e5822.
Crossref
Crossref
Wen-Bin Zhong, Yuan-Chin Tsai, Li-Han Chin, Jen-Ho Tseng, Li-Wen Tang, Steve Horng, Yu-Ching Fan & Sung-Po Hsu. (2018) A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model. International Journal of Molecular Sciences 19:7, pages 1834.
Crossref
Crossref
Mei-Chieh Chen, Yuan-Chin Tsai, Jen-Ho Tseng, Jr-Jiun Liou, Steve Horng, Heng-Ching Wen, Yu-Ching Fan, Wen-Bin Zhong & Sung-Po Hsu. (2017) Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer. International Journal of Molecular Sciences 18:12, pages 2690.
Crossref
Crossref
Asma Fourati, Olfa El Amine, Wided Ben Ayoub, Imen Cherni, Aida Goucha, Michèle Véronique El May, Amor Gamoudi & Ahmed El May. (2017) Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients. Bulletin du Cancer 104:5, pages 433-441.
Crossref
Crossref
Malek Mseddi, Riadh Ben Mansour, Naourez Gouiia, Fatma Mnif, Rabï Bousselaa, Mohamed Abid, Tahia Boudaouara, Hamadi Attia & Saloua Lassoued. (2017) A comparative study of nuclear 8-hydroxyguanosine expression in Autoimmune Thyroid Diseases and Papillary Thyroid Carcinoma and its relationship with p53, Bcl-2 and Ki-67 cancer related proteins. Advances in Medical Sciences 62:1, pages 45-51.
Crossref
Crossref
Catarina Tavares, Miguel Melo, José Manuel Cameselle-Teijeiro, Paula Soares & Manuel Sobrinho-Simões. (2016) ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome. European Journal of Endocrinology 174:4, pages R117-R126.
Crossref
Crossref
Haiyan LiuFan Lin. (2015) Application of Immunohistochemistry in Thyroid Pathology. Archives of Pathology & Laboratory Medicine 139:1, pages 67-82.
Crossref
Crossref
Ryan Chu, Andrew van Hasselt, Alexander C. Vlantis, Enders K. W. Ng, Shirley Y. W. Liu, Michael Dahua Fan, Siu Kwan Ng, Amy B. W. Chan, Zhimin Liu, Xin-ying Li & George G. Chen. (2014) The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer. Cancer 120:1, pages 142-153.
Crossref
Crossref